Back to News
Market Impact: 0.3
Boston Scientific Again Trims FY26 Outlook
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Boston Scientific reported third-quarter financial results and provided adjusted earnings and sales-growth guidance for the fourth quarter. The company also trimmed its full-year 2026 outlook; the article does not specify the guidance figures or the size of the reduction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
BSX-0.55
More News
- Stock Movers:Vertiv, GE Healthcare, Boston Scientific (Podcast)
- Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off